Interest in electronic prescribing of controlled substances (EPCS) continues to increase as hospitals and health systems across the U.S. look for technology solutions to reduce the risk of altered, stolen or fraudulent prescriptions, improve patient safety and satisfaction, and reduce prescription errors and inaccuracies.

When the Drug Enforcement Administration (DEA) introduced regulations for electronic prescribing of controlled substances (EPCS) in 2010, many providers worried that EPCS’s strict security stipulations would disrupt their prescribing workflows. Since then, New York State’s groundbreaking I-STOP legislation and the public debate about mandating EPCS in other states, has driven innovations in health technology that drive EPCS adoption.

For more information click here. 

Prescription drug overdoses are responsible for more deaths in the United States than gun, knife, and motor vehicle injuries combined, with those involving opioid analgesics increasing 300% since 1999. 

Erin Bastick
February 11, 2015

Imprivata has launched a new product to enable a major shift from paper to elctronic prescribing of controlled substances.

Cambridge Health Alliance will be among the first big hospital operators in the state to roll out new technology that allows doctors to electronically send prescriptions for controlled substances directly to pharmacies. Hospital officials say next month’s small but important software upgrade will improve monitoring of prescriptions and reduce fraud and counterfeiting.